A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis.
CLICK HERE FOR MORE INFORMATION:

The Study
- Eosinophilic Esophagitis {EoE) is a chronic allergic/immunologic condition where white blood cells, called eosinophils, overpopulate and reside in the esophagus.
- Eosinophils can release harmful substances that cause inflammation.
- Chronic inflammation of the esophagus can lead to narrowing, leading to difficulty and/or pain when swallowing.
Study Benefits
- This investigational drug aims to reduce the number of eosinophils in the esophagus, thus reducing inflammation, pain and swallowing difficulties.
Study Volunteers Must Meet the Following Criteria
- Male or female
- Between ages of 18 and 75 years old
- Must have a previous documented diagnosis of EoE
Study Participant Expectations
- At the beginning and end of the study, we will ask you to undergo an esophageal biopsy to determine how many eosinophils are present in the tissue
Cost
- There is no cost to participate
- If you qualify, you will be compensated up to $625